Povidone

Quick links to important sections

Povidone

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Povidone

What is Povidone? The Antiseptic Iodophor

Povidone-Iodine (PVP-I) is a stable, synthetic chemical complex utilized as a powerful topical antiseptic for skin and mucous membranes. It is classified as an iodophor, a compound where iodine, the active antimicrobial agent, is safely and reversibly bound to a stabilizing synthetic polymer carrier, Polyvinylpyrrolidone (Povidone).


Quick Facts: Povidone-Iodine Identity

Property Description
Active Ingredient Povidone-Iodine (PVP-I)
Form Aqueous Solution, Topical Cream, Ointment, Surgical Scrub
Pharmacological Class Topical Antiseptic, Iodophor
Common Use General disinfection and reduction of microbial contaminants
Origin Synthetic (Polyvinylpyrrolidone carrier)

Defining the Iodophor Class and Composition

Povidone-Iodine is a combination product where the Povidone polymer controls the release of free iodine, which is the active moiety responsible for killing germs. The product is administered via the topical route in several dosage forms. Popular formulations containing this INN include products commonly marketed under trade names like Betadine and Wokadine.

The General Purpose of the Synthetic Carrier

The overall purpose of this synthetic complex is to provide general disinfection with reduced irritation compared to older, non-complexed iodine solutions. The Polyvinylpyrrolidone carrier improves the safety profile and stability of the Iodine. Povidone-Iodine preparations are used as antiseptics for their efficacy and safety profile. Its bactericidal, virucidal, and fungicidal capabilities make it indispensable for maintaining cleanliness and preventing microbial contamination in various settings.

Regulatory References

  1. as detailed by MedlinePlus

What side effects are possible with Povidone?

Possible Side Effects and Safety Information

Adverse reactions to Povidone-Iodine (PVP-I) are officially classified based on the system or organ affected and the documented frequency. The most commonly reported effects are local, application-site reactions, classified under Skin and subcutaneous tissue disorders. These may include transient irritation, redness, and temporary, reversible brown coloration of the skin. Severe skin reactions, such as contact dermatitis or blistering, are less frequent.

Systemic and Serious Reactions

The regulatory safety profile includes documentation of serious, less frequent adverse reactions. These are primarily grouped under Immune system disorders and Endocrine disorders.

  • Immune System: Systemic hypersensitivity reactions are documented, with anaphylactic reactions (including anaphylactic shock) listed as rare but serious concerns.
  • Endocrine System: Excessive or prolonged use, especially over large areas of the body, may lead to systemic iodine absorption. This has been associated with the development of abnormal thyroid function (hypothyroidism or hyperthyroidism), a key safety consideration linked to duration of exposure.

Population and Contextual Safety Constraints

Official labels define specific constraints for certain groups. The use of Povidone-Iodine is contraindicated in infants up to one month of age due to the risk of abnormal thyroid function. Cautions also apply to patients with pre-existing thyroid disorders and those with renal impairment, as iodine absorption may result in toxic levels or affect pre-existing conditions. Regulatory texts also note that Povidone-Iodine may interfere with diagnostic tests, such as those for thyroid function or occult blood in faeces.

Overdose and Emergency Response

Overdose and when to seek help

The officially documented risk of Povidone overdose or toxicity is primarily associated with the misuse of high molecular weight formulations (specifically Povidone K90) via injection (parenteral administration) of products intended for oral use. This scenario leads to a severe and persistent form of toxicity, distinct from typical acute overdoses.

Official Regulatory Profile of Overdose Risk

Official regulatory sources highlight that, unlike low molecular weight Povidone which is readily excreted, the high molecular weight form, when injected, is permanently retained in the body. This retention leads to the progressive accumulation of the substance in vital organs, tissues, and the reticuloendothelial system.

This accumulation, termed Povidone storage disease, is associated with serious long-term adverse effects, including bone marrow affection (e.g., severe anaemia) and pathological fractures. Fatal cases have been reported in individuals, typically former or current injecting drug abusers, due to these serious systemic consequences.

Required Emergency Action

Because the toxicity stems from chronic accumulation following an improper route of administration, the regulatory response has focused on risk mitigation. The products containing high molecular weight Povidone that carried the highest risk of misuse have been subject to regulatory recommendations for the suspension of their marketing authorization. Any history of Povidone misuse by injection resulting in systemic symptoms requires urgent medical evaluation due to the documented potential for serious, permanent, and life-threatening complications.

Therapeutic Uses of Povidone

What Povidone Treats: Main Uses and Benefits

Povidone, commonly used as the topical antiseptic povidone-iodine (PVP-I), plays a role in managing symptoms related to inflammatory or irritative states by providing broad-spectrum antimicrobial support. This preparation is utilized in situations involving certain distressing symptoms related to minor skin injuries. This therapeutic support contributes to improved day-to-day comfort and helps maintain a sense of stability when symptoms are more noticeable.


Support for Minor Wounds and Skin Injuries

This therapeutic domain is commonly used across conditions associated with acute or disruptive episodes that affect the skin. Povidone-iodine is applied in situations involving certain distressing symptoms, such as redness, inflammation, and temporary discomfort. Its key benefit is associated with maintaining functional stability by supporting management of symptoms related to inflammatory or irritative states, which contributes to easing the overall symptom burden.

Quick Fact: Supports Management of Localized Irritation


Symptom Management in Contamination Contexts

This domain covers general clinical scenarios where additional symptomatic support is needed. Povidone-iodine is relevant when symptoms related to irritative states and physiological strain may escalate temporarily. It is used in settings where short-term symptom stabilization is important, supporting the patient during episodes of heightened discomfort.

Regulatory References

  1. NIH DailyMed Povidone Iodine Solution Label

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Povidone-Iodine — Official Regulatory Information

The eligibility profile for Povidone-Iodine (PVP-I) is defined by regulatory authorities based primarily on the risk of systemic iodine absorption. This dictates who is permitted to use the topical antiseptic and who is explicitly prohibited.


Populations with Restricted or Contraindicated Use

Classification Population Group Regulatory Status
Contraindicated Known Hypersensitivity to PVP-I or iodine Prohibition
Contraindicated Hyperthyroidism or manifest thyroid diseases Prohibition
Contraindicated Patients undergoing Radioiodine Treatment Prohibition
Not Recommended Neonates and infants under one month Avoidance/Prohibition
Restricted Use Pregnancy and Lactation Only if strictly indicated and limited
Caution Required Patients with Impaired Renal Function Use with special consideration

Official documents define eligibility by establishing absolute contraindications related to iodine-sensitive conditions and enforcing strict limitations on populations vulnerable to iodine toxicity, such as neonates and pregnant individuals. Use in children under 12 typically requires consulting a healthcare provider, and use on large areas or for prolonged periods is restricted in all populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The following section summarizes official interaction information strictly based on government regulatory documents.


Interaction scope

Medicinal product categories with documented interactions include mercury derivatives, lithium preparations, and various other topical agents such as enzymatic wound preparations, hydrogen peroxide, and silver-containing disinfectants. The mechanistic basis is primarily chemical incompatibility, which leads to mutual inactivation or the formation of caustic compounds. A pharmacodynamic interaction with lithium is also noted due to the potential for increased systemic iodine load affecting thyroid function.

Interaction classifications (High-Level)

Classification Interacting Entity Examples
Contraindicated/Avoided Mercury derivatives, Lithium
Inactivating Enzymatic preparations, Silver compounds, Hydrogen peroxide
Interfering Radioiodine thyroid tests, Urine/stool glucose/haemoglobin tests

Resulting interaction structure

Official interaction statements:

  • Co-administration with mercury derivatives is formally contraindicated due to chemical incompatibility and the formation of a caustic compound.
  • Concurrent use with lithium preparations is restricted or cautioned against due to a documented risk of hypothyroidism when systemic iodine absorption occurs.
  • The efficacy of povidone-iodine is mutually reduced or inactivated when combined with enzymatic components, hydrogen peroxide, or silver-containing preparations.
  • The absorbed iodine can interfere with radioiodine thyroid uptake studies and cause false-positive results in diagnostic tests for haemoglobin or glucose.
  • An interaction risk of developing hyperthyroidism is officially noted for elderly patients and those with pre-existing thyroid dysfunction.

Connection to the overall interaction profile: Regulatory documents define the product’s interaction structure primarily through mandatory restrictions for chemical incompatibility and cautions regarding pharmacodynamic effects on the thyroid due to the potential for iodine absorption, which also necessitates constraints for certain diagnostic procedures.

Mechanism of Action

How Povidone Works

Chemical Oxidation and Microbial Disruption

The mechanism of Povidone-iodine is entirely focused on direct chemical destruction of pathogens, rather than modulating host biological pathways. The povidone polymer acts as a stabilizing carrier and mediates the controlled release of the active agent, free iodine ( I2), at the application site. The interaction type is non-selective chemical oxidation.

Broad-Spectrum Action and Bioburden Control

Free iodine rapidly oxidizes key microbial structures, including the proteins (like enzymes) and lipids that make up the cellular architecture. This chemical modification causes immediate and irreversible damage to the microorganism's core function and integrity, leading to its death. Because the mechanism relies on the oxidation of universally present biological components, it exerts its chemical action across a broad spectrum of microbial life, including bacteria, viruses, fungi, and protozoa. This action leads to the comprehensive reduction of bioburden (the population of pathogens) on the application surface, a core physiological consequence of the mechanism.

Dosage and Administration Information

Povidone-Iodine is administered via non-systemic routes, primarily as a topical agent for skin and wounds, an oropharyngeal rinse, or a specialized ophthalmic preparation for the eye region. Standard dosage forms vary in concentration, including 10% solutions for general topical use and 0.5% solutions for gargling. The frequency of application depends on the context of use.

For general first aid, standard application patterns involve applying a small amount to the affected area, typically one to three times daily. Conversely, pre-operative skin or eye preparation utilizes a single application immediately preceding the procedure. These administration patterns are governed by specific duration limits. Unsupervised topical use for first aid purposes typically does not exceed 7 days, and oropharyngeal use for sore throat is generally limited to not more than 2 days unless a healthcare provider is consulted.

Administration involves following specific procedural steps. For skin applications, the solution is allowed to dry completely before any covering is applied. When used as a gargle, a 10 mL volume is used full strength for 30 seconds and then spit out to avoid swallowing. Specific considerations apply to pediatric populations; for example, children under 12 years of age require consultation for general topical use. In professional settings, pooling of the solution beneath a patient is avoided during pre-operative skin preparation.

Recent Clinical Evidence

Povidone-iodine (PVP-I) is an antiseptic agent widely used for skin and mucous membrane preparation, wound care, and infection prophylaxis. Recent clinical research has focused on optimizing its use and comparing its effectiveness against other antimicrobial solutions across various medical settings.

Efficacy and Comparative Studies

Recent randomized controlled trials (RCTs) and systematic reviews have explored the role of Povidone-iodine in surgical site infection (SSI) prevention. Research has compared its use against other common antiseptics, such as chlorhexidine gluconate (CHG), especially in gynecologic and obstetric surgeries.

Area of Research Key Findings Reported in Studies
Vaginal Antisepsis Some systematic reviews suggest a higher risk of SSI with PVP-I compared to CHG solutions in gynecologic surgery, while other studies indicate similar effectiveness.
Surgical Site Prep Studies evaluating PVP-I for abdominal surgery site preparation have shown that it significantly reduces microbial counts. The comparative benefit over CHG-alcohol solutions remains an area of non-significant difference in some reports.

Other Investigational Uses

Clinical trials have also assessed the agent's application in other areas:

  • Viral Load Reduction: Studies involving nasal irrigation and mouthwash solutions containing PVP-I have investigated its effect on the viral load of certain respiratory pathogens in the nasopharynx and oropharynx. Findings remain varied, but some research suggests a potential for reducing the period of virus detectability.
  • Antiseptic Resistance: The agent has demonstrated activity against certain antibiotic-resistant organisms, such as MRSA, in laboratory settings, which suggests a potential utility in decolonization protocols.

Key Studies & References

  1. Chlorhexidine versus povidone-iodine for surgical site infection prevention: an updated meta-analysis and trial sequential analysis of randomized controlled trials
  2. Combined Nasal, Oropharyngeal Povidone Iodine Plus Glycyrrhizic Acid Sprays, Accelerate Clinical and Laboratory Recovery and Reduces Household Transmission of SARS-CoV-2: A Randomized Placebo-Controlled Clinical Trial
  3. Povidone-Iodine Solution (Human OTC Drug Labeling)

Frequently Asked Questions (FAQ)

Common questions about Povidone (FAQ)


Q: What is the main difference between Povidone and Betadine?

A: Povidone-Iodine is the official, generic name for the active chemical ingredient, which belongs to a class of antiseptics called iodophors. Betadine is simply one of the commonly recognized brand names under which this antiseptic solution is marketed.


Q: Does Povidone cause staining on clothes or skin?

A: Official safety warnings note that the product may cause a temporary, reversible brown coloration of the skin at the application site. Due to its iodine content, it can also cause staining on clothing or other fabrics, so care should be taken during application.


Q: Can Povidone be used on broken skin or open wounds?

A: Official documents describe the product's authorized use as a first aid antiseptic for minor cuts, scrapes, and burns. However, official labeling advises consulting a healthcare provider before using it on deep or puncture wounds, animal bites, or serious burns.


Q: How long does the antiseptic effect of Povidone last after application?

A: Studies and official information indicate the onset of the antiseptic effect is rapid, with microbicidal action often beginning within 30 seconds of contact. Official labeling for general first aid application specifies a frequency of application that is typically one to three times daily.


Q: What happens if Povidone is accidentally swallowed?

A: If the product is accidentally swallowed, official product labels direct users to immediately seek emergency medical help or contact a Poison Control Center right away. Accidental ingestion may potentially lead to symptoms such as abdominal pain or vomiting.


Q: Are there different strengths or concentrations of Povidone available?

A: Yes, Povidone-Iodine is available in various official concentrations. Specific concentrations are available for applications such as general topical use, and other lower concentrations may be used for products like oral gargles.


Q: Can Povidone affect healing time for wounds?

A: Official regulatory information focuses on the product's authorized use to help prevent infection. Its use is limited to short durations, such as not more than seven days for unsupervised first aid, as a constraint to minimize the potential for systemic effects.


Q: What is the difference between Povidone solution and Povidone scrub?

A: Official regulatory documents list several different dosage forms, including Aqueous Solution and Surgical Scrub. The scrub formulation typically contains a detergent, making it specifically intended for pre-operative cleansing, while the solution is for general antiseptic use.


Q: Can Povidone be used on fungal infections?

A: The product's mechanism of action is described in official documents as being broad-spectrum, meaning it demonstrates activity against a wide range of microbial life, which includes bacteria, viruses, and fungi.


Q: Is the brown color of Povidone important for its function?

A: The product's brown color is associated with the presence of the active iodine complex. The fading or complete loss of this characteristic brown color indicates a potential loss of the active iodine ingredient, which is generally associated with product degradation.


Q: Is Povidone the same ingredient as in over-the-counter antiseptic wipes?

A: Povidone-Iodine is listed in official regulatory communications as one of the active ingredients commonly used in various over-the-counter topical antiseptic products. These products include liquids, swabs, and pads saturated with a Povidone-Iodine solution.


Q: Why is Povidone often used in hospital settings?

A: Official regulatory information states that Povidone-Iodine is used for patient pre-operative skin preparation and hand antisepsis. It is favored in these settings due to its documented broad-spectrum antimicrobial activity, which is effective for reducing bacteria that can potentially cause surgical site infections.


Q: Is it common to feel a burning sensation when applying Povidone?

A: Official documents classify the most common adverse effects as local skin reactions, including transient irritation and redness at the application site. Persistent or severe sensations, such as burning, are classified as effects that warrant consultation with a healthcare provider, according to official safety profiles.


Q: Can Povidone be applied more than once a day?

A: For general first aid use, official instructions specify that application to the affected area is typically done one to three times daily. The frequency of application is defined by the official product directions for the specific product type.


Q: Is there a maximum body area size that Povidone should be used on?

A: Official labeling explicitly advises users not to use the product over large areas of the body. This restriction is a safety measure due to the potential for systemic iodine absorption when the product is applied extensively.


Q: Why do some people say Povidone is drying to the skin?

A: Official safety data notes that prolonged exposure to wet solution, or use over large areas, may cause skin irritation or other local adverse effects. This potential for local irritation may be the basis for observations of skin dryness.


Q: How quickly does Povidone start to work after application?

A: Authoritative information indicates the onset of the antiseptic effect is rapid, with microbicidal action often beginning within 30 seconds of contact. This rapid action is achieved through the direct chemical oxidation of microbial structures.


Q: Is it normal for Povidone to change color over time in the bottle?

A: Official storage instructions require the product to be protected from light and excessive heat. The fading or loss of the characteristic brown color is an indicator of the potential loss of the active iodine and suggests the product may be degraded.


Q: Does Povidone contain any alcohol?

A: The official label for many Povidone-Iodine aqueous solutions does not list alcohol as an inactive ingredient. However, official documents indicate that some antiseptic products may contain Povidone-Iodine in combination with alcohol, depending on the specific formulation.


Q: Can Povidone cause skin irritation in people with sensitive skin?

A: Official safety profiles note that the product may cause local irritation and advise users with existing skin conditions or sensitivities to consult their healthcare provider prior to use. Transient irritation and redness are commonly reported adverse effects.


Q: Is there evidence that bacteria become resistant to Povidone?

A: Authoritative research summarized in medical literature suggests that, unlike common antibiotics, resistance and cross-resistance against Povidone-Iodine's active agent (iodine) have not been exhibited.


Q: Why is Povidone often used as a preparation before surgery?

A: Povidone-Iodine is officially indicated for use as a patient pre-operative skin preparation. Its primary purpose in this context is to help reduce bacteria on the skin that can potentially cause a surgical site infection.


Q: What happens if a large area of skin treated with Povidone is covered with a bandage?

A: Official guidelines state the product must be allowed to dry completely before being covered with a bandage. Covering skin that is still wet, especially over a large area, may increase the risk of skin irritation or severe skin reactions.

How should Povidone be stored and disposed of?

How to Store and Dispose of Povidone-Iodine

Povidone-Iodine (PVP-I) must be stored strictly according to official regulatory labeling to ensure product stability.

Official Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 15 C to 30 C (59 F to 86 F).
Environment Protect from freezing and excessive heat. Keep the container tightly closed and protected from light.
Child Safety Mandatory to Keep Out of Reach of Children.

Disposal

Single-use products, such as pads and swabsticks, must be discarded immediately after first use. Unused or expired Povidone-Iodine must be disposed of in accordance with local, state, and federal regulations. Disposal into public waters is prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Povidone found in:

A-Z Index: